Credit Suisse Maintains Outperform on HCA Healthcare, Raises Price Target to $316
Portfolio Pulse from Benzinga Newsdesk
Credit Suisse analyst A.J. Rice maintains an Outperform rating on HCA Healthcare (NYSE:HCA) and raises the price target from $311 to $316.
July 28, 2023 | 2:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Credit Suisse maintains an Outperform rating on HCA Healthcare and raises the price target from $311 to $316, which could positively impact the stock.
The Outperform rating maintained by Credit Suisse indicates that the firm expects HCA Healthcare to outperform the market or its sector in the short term. The increase in the price target from $311 to $316 suggests that the firm sees more upside potential in the stock, which could lead to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100